The increasing availability of high-technology care, such as cardiac surgery, raises questions regarding patients’ rehabilitation in the post-surgical period. Recently, the development and maintenance of Centers for Cardiac Surgery all over the Russian Federation has been a major focus of medical community. However, less attention has been directed toward the issue of post-surgical rehabilitation.
The search for new pharmaceutical agents and methods of rehabilitation is a promising direction for the development of rehabilitation medicine. The present study reports the potential use of taurine during the recovery period following coronary bypass surgery or heart valve replacement surgery.
In patients undergoing heart valve replacement and coronary bypass surgery, the use of taurine results in an increase in left ventricular ejection fraction and a reduction in left ventricular myocardial mass index and triglyceride levels. The quality of life improved significantly. The results of “WAM” testing demonstrated the improved parameters of Well-being, Activity and Mood in the patients enrolled into the Taurine arm.